Lv3
342 积分 2024-10-14 加入
Pharmacology and pharmacokinetics of antibody-drug conjugates, where do we stand?
2天前
已完结
The path via pathway-based approaches towards safety assessment: A concise review
2天前
已完结
Drug metabolizing enzymes and transporters, and their roles for the development of drug-induced liver injury
2天前
已完结
Biochemistry of Drug Metabolizing Enzymes
2天前
已完结
Current hPSC-derived liver organoids for toxicity testing: Cytochrome P450 enzymes and drug metabolism
2天前
已完结
Investigating the link between drug metabolism and toxicity
3天前
已完结
Nonclinical teratogenicity safety assessment of CRBN-engaging targeted protein degraders: Points to consider
3天前
已完结
The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered Optional
4天前
已完结
Points to consider for revising the ICH S7A guideline on safety and secondary pharmacology
4天前
已完结
皖公网安备34019202002308
